Skip to main content
CELU
NASDAQ Life Sciences

Celularity Files 10-K, Regains Nasdaq Compliance, Highlights Strategic Shift

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.02
Mkt Cap
$27.598M
52W Low
$0.931
52W High
$4.35
52W Position info
9.6% above low
Off High info
77% below high
Rel. Volume info
3.1× avg
Market data snapshot near publication time

CELU is trading near its 52-week low of $0.931 (9.6% above the low) on elevated volume (3.1× avg).

Summary

Celularity Inc. has filed its Annual Report on Form 10-K for fiscal year 2025, successfully regaining compliance with Nasdaq's listing requirements for timely financial reporting. This resolves a previously disclosed non-compliance notification received on April 16, 2026, which posed a delisting threat. The company also highlighted its ongoing strategic transformation, which includes the out-licensing of its biomaterials portfolio, personnel realignment, and a significant $13 million reduction in liabilities. While the debt reduction was previously announced in an April 21st 8-K, the filing of the 10-K and the confirmed resolution of the Nasdaq compliance issue are critical for maintaining investor confidence and market access for this micro-cap company. Traders will now look for continued execution on the company's refocused longevity and cell therapy strategy.

At the time of this announcement, CELU was trading at $1.02 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $27.6M. The 52-week trading range was $0.93 to $4.35. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

CELU - Latest Insights

CELU
Oct 28, 2026, 5:52 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $0.980
Real-time Price: $0.8088 info
Change: -$0.1712 (-17%) info
Market Cap: $26.246M info
CELU
Oct 20, 2026, 5:08 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $0.8088 info
Change: -$0.4512 (-36%) info
Market Cap: $26.246M info
CELU
Oct 05, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.62
Real-time Price: $0.8088 info
Change: -$0.8062 (-50%) info
Market Cap: $26.246M info
CELU
Sep 29, 2026, 5:02 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.39
Real-time Price: $0.8088 info
Change: -$0.5812 (-42%) info
Market Cap: $26.246M info
CELU
Sep 28, 2026, 1:14 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.39
Real-time Price: $0.8088 info
Change: -$0.5812 (-42%) info
Market Cap: $26.246M info